Hypovitaminosis D and metabolic syndrome;Hipovitaminosis D y síndrome metabólico

Medicina Clinica

Volumn 143, Issue 12, 2014, Pages 542-547

  Miñambres, Inka ^a,b   De Leiva, Alberto ^a,b,c   Pérez, Antonio ^a,b,d  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Diabetes; Metabolic syndrome; Vitamin D

Indexed keywords

VITAMIN D; BIOLOGICAL MARKER;

HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; COMPLICATION; METABOLISM; PHYSIOLOGY; RISK FACTOR;

BIOLOGICAL MARKERS; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84914158184     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2013.12.012     Document Type: Review

References (53)

1. D.E. Laaksonen, H.M. Lakka, L.K. Niskanen, G.A. Kaplan, J.T. Salonen, and T.A. Lakka Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study Am J Epidemiol 156 2002 1070 1077
2. J.K. Ninomiya, G. L'Italien, M.H. Criqui, J.L. Whyte, A. Gamst, and R.S. Chen Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey Circulation 109 2004 42 46
3. K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 2009 1640 1645
4. S.M. Grundy Metabolic syndrome: Connecting and reconciling cardiovascular and diabetes worlds J Am Coll Cardiol 47 2006 1093 1100
5. L. Wang, Y. Song, J.E. Manson, S. Pilz, W. Marz, and K. Michaelsson Circulating 25-hydroxy-vitamin d and risk of cardiovascular disease: A meta-analysis of prospective studies Circ Cardiovasc Qual Outcomes 5 2012 819 829
6. M.F. Holick Environmental factors that influence the cutaneous production of vitamin D Am J Clin Nutr 61 1995 638S 645S
7. M.F. Holick Vitamin D deficiency N Engl J Med 357 2007 266 281
8. T.C. Chen, F. Chimeh, Z. Lu, J. Mathieu, K.S. Person, and A. Zhang Factors that influence the cutaneous synthesis and dietary sources of vitamin D Arch Biochem Biophys 460 2007 213 217
9. C.J. Rosen, J.S. Adams, D.D. Bikle, D.M. Black, M.B. Demay, and J.E. Manson The nonskeletal effects of vitamin D: An endocrine society scientific statement Endocr Rev 33 2012 456 492
10. M.F. Holick The use and interpretation of assays for vitamin D and its metabolites J Nutr 120 1990 1464 1469
11. P. Lips Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications Endocr Rev 22 2001 477 501
12. M.F. Holick, N.C. Binkley, H.A. Bischoff-Ferrari, C.M. Gordon, D.A. Hanley, and R.P. Heaney Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited J Clin Endocrinol Metab 97 2012 1153 1158
13. A.C. Ross, J.E. Manson, S.A. Abrams, J.F. Aloia, P.M. Brannon, and S.K. Clinton The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know J Clin Endocrinol Metab 96 2011 53 58
14. I. Gonzalez-Molero, S. Morcillo, S. Valdes, V. Perez-Valero, P. Botas, and E. Delgado Vitamin D deficiency in Spain: A population-based cohort study Eur J Clin Nutr 65 2011 321 328
15. C. Fan, F.J. Nieto, L.E. Bautista, and J.P. Fine Vitamin D intake and cardiovascular mortality in the NHANES I epidemiological follow-up study cohort J Diet Suppl 9 2012 79 89
16. E.S. Ford, G. Zhao, J. Tsai, and C. Li Vitamin D and all-cause mortality among adults in USA: Findings from the National Health and Nutrition Examination Survey Linked Mortality Study Int J Epidemiol 40 2011 998 1005
17. E.S. Ford, U.A. Ajani, L.C. McGuire, and S. Liu Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults Diabetes Care 28 2005 1228 1230
18. K.C. Maki, V.L. Fulgoni 3rd, D.R. Keast, T.M. Rains, K.M. Park, and M.R. Rubin Vitamin D intake and status are associated with lower prevalence of metabolic syndrome in U.S. adults: National Health and Nutrition Examination Surveys 2003-2006 Metab Syndr Relat Disord 10 2012 363 372
19. J.P. Reis, D. von Muhlen, and E.R. Miller 3rd. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults Eur J Endocrinol 159 2008 41 48
20. D.M. Lee, M.K. Rutter, T.W. O'Neill, S. Boonen, D. Vanderschueren, and R. Bouillon Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men Eur J Endocrinol 161 2009 947 954
21. E. Hyppönen, B.J. Boucher, D.J. Berry, and C. Power 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: A cross-sectional study in the 1958 British Birth Cohort Diabetes 57 2008 298 305
22. M.K. Kim, M. Il Kang, K. Won Oh, H.S. Kwon, J.H. Lee, and W.C. Lee The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects Clin Endocrinol (Oxf) 73 2010 330 338
23. F.M. Moy, and A. Bulgiba High prevalence of vitamin D insufficiency and its association with obesity and metabolic syndrome among Malay adults in Kuala Lumpur, Malaysia BMC Public Health 11 2011 735
24. I. Miñambres, J. Sánchez-Hernández, J.L. Sanchez-Quesada, J. Rodríguez, A. de Leiva, and A. Pérez The association of hypovitaminosis D with the metabolic syndrome is independent of the degree of obesity ISRN Endocrinol 2012 2012 691803
25. H. Khan, S. Kunutsor, O.H. Franco, and R. Chowdhury Vitamin D, type 2 diabetes and other metabolic outcomes: A systematic review and meta-analysis of prospective studies Proc Nutr Soc 72 2013 89 97
26. S. Wongwiwatthananukit, N. Sansanayudh, N. Phetkrajaysang, and S. Krittiyanunt Effects of vitamin D2 supplementation on insulin sensitivity and metabolic parameters in metabolic syndrome patients J Endocrinol Invest 36 2013 558 563
27. J. Ybarra, J. Sanchez-Hernandez, I. Gich, A. de Leiva, X. Rius, and J. Rodriguez-Espinosa Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery Obes Surg 15 2005 330 335
28. M.B. Snijder, R.M. van Dam, M. Visser, D.J. Deeg, J.M. Dekker, and L.M. Bouter Adiposity in relation to vitamin D status and parathyroid hormone levels: A population-based study in older men and women J Clin Endocrinol Metab 90 2005 4119 4123
29. S. Cheng, J.M. Massaro, C.S. Fox, M.G. Larson, M.J. Keyes, and E.L. McCabe Adiposity, cardiometabolic risk, and vitamin D status: The Framingham Heart Study Diabetes 59 2010 242 248
30. C.P. Earthman, L.M. Beckman, K. Masodkar, and S.D. Sibley The link between obesity and low circulating 25-hydroxyvitamin D concentrations: Considerations and implications Int J Obes (Lond) 36 2012 387 396
31. C. Ding, D. Gao, J. Wilding, P. Trayhurn, and C. Bing Vitamin D signalling in adipose tissue Br J Nutr 108 2012 1915 1923
32. E. Lin, D. Armstrong-Moore, Z. Liang, J.F. Sweeney, W.E. Torres, and T.R. Ziegler Contribution of adipose tissue to plasma 25-hydroxyvitamin D concentrations during weight loss following gastric bypass surgery Obesity (Silver Spring) 19 2011 588 594
33. T. Tzotzas, F.G. Papadopoulou, K. Tziomalos, S. Karras, K. Gastaris, and P. Perros Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance J Clin Endocrinol Metab 95 2010 4251 4257
34. R. Scragg, M. Sowers, and C. Bell Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey Diabetes Care 27 2004 2813 2818
35. S. Afzal, S.E. Bojesen, and B.G. Nordestgaard Low 25-hydroxyvitamin D and risk of type 2 diabetes: A prospective cohort study and metaanalysis Clin Chem 59 2013 381 391
36. A.G. Pittas, J. Lau, F.B. Hu, and B. Dawson-Hughes The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis J Clin Endocrinol Metab 92 2007 2017 2029
37. C. Mathieu, C. Gysemans, A. Giulietti, and R. Bouillon Vitamin D and diabetes Diabetologia 48 2005 1247 1257
38. S. Kayaniyil, R. Vieth, R. Retnakaran, J.A. Knight, Y. Qi, and H.C. Gerstein Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes Diabetes Care 33 2010 1379 1381
39. E. Hyppönen Vitamin D and increasing incidence of type 1 diabetes-evidence for an association? Diabetes Obes Metab 12 2010 737 743
40. P.S. George, E.R. Pearson, and M.D. Witham Effect of vitamin D supplementation on glycaemic control and insulin resistance: A systematic review and meta-analysis Diabet Med 29 2012 e142 e150
41. S. Nagasaka, T. Murakami, T. Uchikawa, S.E. Ishikawa, and T. Saito Effect of glycemic control on calcium and phosphorus handling and parathyroid hormone level in patients with non-insulin-dependent diabetes mellitus Endocr J 42 1995 377 383
42. S. Sayinalp, O. Gedik, and Z. Koray Increasing serum osteocalcin after glycemic control in diabetic men Calcif Tissue Int 57 1995 422 425
43. H. Ishida, Y. Seino, K. Tsuda, J. Takemura, S. Nishi, and S. Ishizuka Effects of streptozotocin-induced diabetes on circulating levels of vitamin D metabolites Acta Endocrinol (Copenh) 104 1983 96 102
44. B.L. Nyomba, R. Bouillon, W. Lissens, H. Van Baelen, and P. De Moor 1,25-Dihydroxyvitamin D and vitamin D-binding protein are both decreased in streptozotocin-diabetic rats Endocrinology 116 1985 2483 2488
45. A. Burgaz, N. Orsini, S.C. Larsson, and A. Wolk Blood 25-hydroxyvitamin D concentration and hypertension: A meta-analysis J Hypertens 29 2011 636 645
46. S.K. Kunutsor, T.A. Apekey, and M. Steur Vitamin D and risk of future hypertension: Meta-analysis of 283,537 participants Eur J Epidemiol 28 2013 205 221
47. T.J. Wang, M.J. Pencina, S.L. Booth, P.F. Jacques, E. Ingelsson, and K. Lanier Vitamin D deficiency and risk of cardiovascular disease Circulation 117 2008 503 511
48. G.S. Brinton, W. Jubiz, and L.D. Lagerquist Hypertension in primary hyperparathyroidism: The role of the renin-angiotensin system J Clin Endocrinol Metab 41 1975 1025 1029
49. M.D. Witham, M.A. Nadir, and A.D. Struthers Effect of vitamin D on blood pressure: A systematic review and meta-analysis J Hypertens 27 2009 1948 1954
50. R. Jorde, and G. Grimnes Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids Prog Lipid Res 50 2011 303 312
51. D.S. Grimes Statins and vitamin D: editorial to: "increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins?" by Bunyamin Yavuz et al Cardiovasc Drugs Ther 23 2009 261 262
52. M.B. Elamin, N.O. Abu Elnour, K.B. Elamin, M.M. Fatourechi, A.A. Alkatib, and J.P. Almandoz Vitamin D and cardiovascular outcomes: A systematic review and meta-analysis J Clin Endocrinol Metab 96 2011 1931 1942
53. J.E. Manson, S.S. Bassuk, I.M. Lee, N.R. Cook, M.A. Albert, and D. Gordon The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease Contemp Clin Trials 33 2012 159 171